Dentalcorp Announces Annual General Meeting Voting Results

TORONTO--(BUSINESS WIRE)-- dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company"), (TSX: DNTL) Canada’s largest and one of North America's fastest growing networks of dental practices, announced today the results of its Annual General and Special Meeting of Shareholders ("AGM") held on Thursday, May 22, 2025.

At the AGM, Dentalcorp shareholders voted on the following matters, the full details of which are set out in the Company’s management information circular dated April 11, 2025, issued in connection with the AGM, which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

1. At the AGM, the following eight individuals nominated to serve on Dentalcorp’s Board of Directors (the "Board"), were elected by shareholders as follows:

2. At the AGM, Ernst & Young LLP were re-appointed as Dentalcorp's auditors to hold office until the next annual general meeting of the Company’s shareholders and the Board was authorized to fix their remuneration, as an ordinary resolution of shareholders as follows:

3. At the AGM, amendments to the Company’s Equity Incentive Plan were approved by ballot as set forth below:

4. At the AGM, amendments to the Company’s Legacy Option Plan were approved by ballot as set forth below:

5. At the AGM, amendments to the Company’s Deferred Share Unit were approved by ballot as set forth below:

A full report of voting results from the Meeting is available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

About Dentalcorp

Dentalcorp is Canada's largest and one of North America's fastest growing networks of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and unforgettable experiences. Dentalcorp acquires leading dental practices, uniting its network in a common goal: to be Canada's most trusted healthcare network. Leveraging its industry-leading technology, know-how and scale, Dentalcorp offers professionals the unique opportunity to retain their clinical autonomy while unlocking their potential for future growth. To learn more, visit dentalcorp.ca.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522149787/en/

For investor inquiries, please contact:
[email protected]

Source: dentalcorp Holdings Ltd.

You May Also Be Interested In

• Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
• Giant Pandas Ping Ping and Fu Shuang Arrive in Atlanta on the FedEx Panda Express 
• Global Running Boom Takes Center Stage at Sold-Out Life Time Chicago Half Marathon & 5K